These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 34165501)
1. Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial. Hui Z; Men Y; Hu C; Kang J; Sun X; Bi N; Zhou Z; Liang J; Lv J; Feng Q; Xiao Z; Chen D; Wang Y; Li J; Wang J; Gao S; Wang L; He J JAMA Oncol; 2021 Aug; 7(8):1178-1185. PubMed ID: 34165501 [TBL] [Abstract][Full Text] [Related]
2. Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins. Yuan M; Men Y; Kang J; Sun X; Zhao M; Bao Y; Yang X; Sun S; Ma Z; Wang J; Deng L; Wang W; Zhai Y; Liu W; Zhang T; Wang X; Bi N; Lv J; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Wang L; Hui Z Thorac Cancer; 2021 Jan; 12(2):227-234. PubMed ID: 33247556 [TBL] [Abstract][Full Text] [Related]
3. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma. Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Jiang H; Ming Wang J; Li B Radiol Oncol; 2020 Dec; 55(1):66-76. PubMed ID: 33885242 [TBL] [Abstract][Full Text] [Related]
4. Postoperative radiotherapy in pIIIA-N2 non-small cell lung cancer after complete resection and adjuvant chemotherapy: A meta-analysis. Wang SF; Mao NQ; Zhao WH; Pan XB Medicine (Baltimore); 2022 Jul; 101(28):e29550. PubMed ID: 35839025 [TBL] [Abstract][Full Text] [Related]
5. Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer. Brandt WS; Yan W; Leeman JE; Tan KS; Park BJ; Adusumilli PS; Bott MJ; Molena D; Isbell J; Chaft J; Rimner A; Jones DR Ann Thorac Surg; 2018 Sep; 106(3):848-855. PubMed ID: 29807005 [TBL] [Abstract][Full Text] [Related]
6. Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy. Wang W; Men Y; Wang J; Zhou Z; Chen D; Xiao Z; Feng Q; Lv J; Liang J; Bi N; Gao S; Wang L; Hui Z BMC Cancer; 2019 May; 19(1):478. PubMed ID: 31113432 [TBL] [Abstract][Full Text] [Related]
7. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume. Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006 [TBL] [Abstract][Full Text] [Related]
8. The effect of postoperative radiotherapy on the survival of patients with resectable stage III-N2 non-small-cell lung cancer: a systematic review and meta-analysis. Zhang H; Zhang DX; Ju T; Zhou J Neoplasma; 2019 Sep; 66(5):717-726. PubMed ID: 31129967 [TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. Le Pechoux C; Pourel N; Barlesi F; Lerouge D; Antoni D; Lamezec B; Nestle U; Boisselier P; Dansin E; Paumier A; Peignaux K; Thillays F; Zalcman G; Madelaine J; Pichon E; Larrouy A; Lavole A; Argo-Leignel D; Derollez M; Faivre-Finn C; Hatton MQ; Riesterer O; Bouvier-Morel E; Dunant A; Edwards JG; Thomas PA; Mercier O; Bardet A Lancet Oncol; 2022 Jan; 23(1):104-114. PubMed ID: 34919827 [TBL] [Abstract][Full Text] [Related]
10. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy. Yang H; Wang K; Li S; Li Y; Yuan L Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289 [No Abstract] [Full Text] [Related]
11. Uncertain resection of highest mediastinal lymph node positive among pN2 non-small cell lung cancer patients: survival analysis of postoperative radiotherapy and driver gene mutations. Deng Q; Wang H; Xiu W; Tian X; Gong Y Jpn J Radiol; 2023 May; 41(5):551-560. PubMed ID: 36484979 [TBL] [Abstract][Full Text] [Related]
12. ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy. Yang X; Wang L; Jin X; Xu R; Yu Z; Li H; Lu H; An N Front Oncol; 2023; 13():1158104. PubMed ID: 37188197 [TBL] [Abstract][Full Text] [Related]
13. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis. Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882 [TBL] [Abstract][Full Text] [Related]
14. Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base. Robinson CG; Patel AP; Bradley JD; DeWees T; Waqar SN; Morgensztern D; Baggstrom MQ; Govindan R; Bell JM; Guthrie TJ; Colditz GA; Crabtree TD; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V J Clin Oncol; 2015 Mar; 33(8):870-6. PubMed ID: 25667283 [TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution. Dai H; Hui Z; Ji W; Liang J; Lu J; Ou G; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; He J; Wang L Oncologist; 2011; 16(5):641-50. PubMed ID: 21482587 [TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer. Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935 [TBL] [Abstract][Full Text] [Related]
17. The high-risk features and effect of postoperative radiotherapy on survival for patients with surgically treated stage IIIA-N2 non-small cell lung cancer. Zhu M; Li S; Yuan L; Liu S; Li J; Zhang D; Chen J; Jiang J; Xu Z World J Surg Oncol; 2023 Aug; 21(1):238. PubMed ID: 37537652 [TBL] [Abstract][Full Text] [Related]
18. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA; Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766 [TBL] [Abstract][Full Text] [Related]
19. Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer. Xu Y; Li J; Wang J; Hu X; Ma H; Li P; Zheng X; Chen M Oncol Lett; 2018 Feb; 15(2):2641-2650. PubMed ID: 29434986 [TBL] [Abstract][Full Text] [Related]
20. Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer. Lee HW; Noh OK; Oh YT; Choi JH; Chun M; Kim HI; Heo J; Ahn MS; Park SY; Park RW; Yoon D Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):621-7. PubMed ID: 26867891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]